|
시장보고서
상품코드
1991415
조직 처리 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Tissue Processing System Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
조직 처리 시스템 시장 규모는 2025년 4억 7,393만 달러에서 2026년부터 2034년까지 CAGR 6.61%로 성장하여 2034년에는 8억 4,314만 달러에 달할 것으로 예측됩니다.
정확하고 효율적인 병리 진단에 대한 수요가 증가함에 따라 세계 조직 처리 시스템 시장은 꾸준히 성장하고 있습니다. 조직 처리 시스템은 현미경 검사를 위해 생물학적 조직 샘플을 준비하는 데 사용되는 필수적인 실험실 장비입니다. 특히 암의 검출 및 연구 개발에서 진단 절차의 수가 증가함에 따라 실험실에서는 자동화된 조직 처리 기술이 도입되고 있습니다. 실험실 자동화의 발전과 진단 워크플로우의 개선은 병원과 연구소의 시장 발전에 크게 기여하고 있습니다.
조직 처리 시스템 시장의 성장을 이끄는 몇 가지 요인이 있습니다. 전 세계적으로 암 및 기타 만성질환의 유병률이 증가함에 따라 병리 검사에 대한 수요가 증가하고 있습니다. 병원과 진단 검사실은 처리시간 단축과 검체 보존성 향상을 위한 첨단 시스템에 대한 투자를 진행하고 있습니다. 또한 의학 연구, 생명공학, 맞춤의료에 대한 투자 확대도 첨단 조직 분석 장비의 활용을 촉진하고 있습니다.
의료 시스템이 검사실 인프라를 계속 현대화함에 따라 조직 처리 시스템 시장의 향후 전망은 계속 밝습니다. 완전 자동화 및 고처리량 시스템 도입으로 병리검사실의 효율성이 향상되고 인위적인 실수가 감소할 것으로 예상됩니다. 신흥국도 진단 역량을 확대하며 새로운 성장 기회를 창출하고 있습니다. 정밀의료와 첨단 질병 검출 기법의 중요성이 높아짐에 따라 신뢰할 수 있는 조직 처리 기술에 대한 수요는 더욱 증가할 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 조직 처리 시스템 시장 : 제품 유형별
제5장 세계의 조직 처리 시스템 시장 : 용도별
제6장 세계의 조직 처리 시스템 시장 : 최종사용자별
제7장 세계의 조직 처리 시스템 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.27The Tissue Processing System Market size is expected to reach USD 843.14 Million in 2034 from USD 473.93 Million (2025) growing at a CAGR of 6.61% during 2026-2034.
The global tissue processing system market has grown steadily due to increasing demand for accurate and efficient pathology diagnostics. Tissue processing systems are essential laboratory devices used to prepare biological tissue samples for microscopic examination. As the number of diagnostic procedures rises, particularly in cancer detection and research, laboratories are adopting automated tissue processing technologies. Advances in laboratory automation and improvements in diagnostic workflows have significantly contributed to the market's development across hospitals and research institutions.
Several factors are driving the growth of the tissue processing system market. The increasing global prevalence of cancer and other chronic diseases has created greater demand for pathology testing. Hospitals and diagnostic laboratories are investing in advanced systems that offer faster processing times and improved sample preservation. In addition, growing investments in medical research, biotechnology, and personalized medicine are encouraging the use of advanced tissue analysis equipment.
The future outlook for the tissue processing system market remains positive as healthcare systems continue to modernize laboratory infrastructure. The adoption of fully automated and high-throughput systems is expected to improve efficiency and reduce manual errors in pathology laboratories. Emerging economies are also expanding their diagnostic capabilities, creating new growth opportunities. As precision medicine and advanced disease detection methods gain importance, demand for reliable tissue processing technologies is likely to increase further.
MARKET SEGMENTATION
By Product Type
- Automated Tissue Processors
- Semi-Automated Tissue Processors
- Manual Tissue Processors
By Application
- Histopathology
- Cytopathology
- Hematopathology
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
COMPANIES PROFILED
- Leica Biosystems, Thermo Fisher Scientific Inc, Sakura Finetek USA Inc, Milestone Medical Technologies Inc, BioGenex Laboratories, Agilent Technologies Inc, Merck KGaA, Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, PerkinElmer Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Automated Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Semi-Automated Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Manual Tissue Processors Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Histopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cytopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Hematopathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY END USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End User
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL TISSUE PROCESSING SYSTEM MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End User
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End User
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End User
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End User
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End User
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL TISSUE PROCESSING SYSTEM INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Leica Biosystems
- 9.2.2 Thermo Fisher Scientific Inc
- 9.2.3 Sakura Finetek USA Inc
- 9.2.4 Milestone Medical Technologies Inc
- 9.2.5 BioGenex Laboratories
- 9.2.6 Agilent Technologies Inc
- 9.2.7 Merck KGaA
- 9.2.8 Danaher Corporation
- 9.2.9 Roche Diagnostics
- 9.2.10 Siemens Healthineers AG
- 9.2.11 PerkinElmer Inc
